Clinical Trials · NCT06154187
Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With Osteoporosis
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- Pharmbio Korea Co., Ltd.
- Enrollment
- 60
- Start date
- Feb 2024
- Locations
- 1 site, South Korea
- Primary endpoint
- Bone mineral density (BMD) change rate